KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Cash from Financing Activities (2016 - 2025)

Cvs Health's Cash from Financing Activities history spans 17 years, with the latest figure at -$2.0 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 571.46% year-over-year to -$2.0 billion, compared with a TTM value of -$4.9 billion through Dec 2025, down 335.24%, and an annual FY2025 reading of -$4.9 billion, down 335.24% over the prior year.
  • Cash from Financing Activities for Q4 2025 was -$2.0 billion at Cvs Health, down from -$1.4 billion in the prior quarter.
  • The five-year high for Cash from Financing Activities was $3.6 billion in Q2 2023, with the low at -$3.3 billion in Q2 2021.
  • Average Cash from Financing Activities over 5 years is -$1.3 billion, with a median of -$2.0 billion recorded in 2021.
  • Year-over-year, Cash from Financing Activities soared 247.34% in 2023 and then plummeted 571.46% in 2025.
  • Tracing CVS's Cash from Financing Activities over 5 years: stood at -$2.9 billion in 2021, then increased by 24.95% to -$2.2 billion in 2022, then skyrocketed by 55.56% to -$972.0 million in 2023, then surged by 144.34% to $431.0 million in 2024, then plummeted by 571.46% to -$2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Cash from Financing Activities are -$2.0 billion (Q4 2025), -$1.4 billion (Q3 2025), and $806.0 million (Q2 2025).